Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Relationship between vitamin D deficiency and visually evoked potentials in multiple sclerosis.
A web-based decision support tool for prognosis simulation in multiple sclerosis.
Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosis.
Pediatric-Onset Multiple Sclerosis Disease Progression in Kuwait: A Retrospective Analysis.
FTY720 (Fingolimod) sensitizes hepatocellular carcinoma cells to sorafenib-mediated cytotoxicity.
Loss of Mobility and the Patient Burden of Multiple Sclerosis: Expert Opinion on Relevance to Daily Clinical Practice.
Lyme disease associated neuroretinitis - Case report.
Aquaporin-4 immuneglobulin g testing in 36 consecutive jamaican patients with inflammatory central nervous system demyelinating disease.
Effects of pooled human immunoglobulins in an animal model of neuromyelitis optica with chronic application of autoantibodies to aquaporin 4.
Immune cell dynamics in the CNS: Learning from the zebrafish.
Accuracy and Reproducibility of a Quantitative Magnetic Resonance Imaging Method for Concurrent Measurements of Tissue Relaxation Times and Proton Density.
A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis.
From mishap to model: The origins and utility of experimental autoimmune encephalomyelitis.
Modulation of kallikrein-kinin system by the angiotensin-converting enzyme inhibitor alleviates experimental autoimmune encephalomyelitis.
Matrix Metalloproteinases, New Insights into the Understanding of Neurodegenerative Disorders.
From the fundamentals of multiple sclerosis to clinical management.
Stop the silent misdiagnosis: patients' preferences matter.
Multiple sclerosis in malaysia: demographics, clinical features, and neuroimaging characteristics.
Docosahexaenoic Acid and Cognition throughout the Lifespan.
Examining the effects of comorbidities on disease-modifying therapy use in multiple sclerosis.
Oxidative stress and antioxidants in neurological diseases: is there still hope?
Adult-Onset Leukoencephalopathies.
Increased contrast enhancing lesion activity in relapsing-remitting multiple sclerosis migraine patients.
Detection of aquaporin-4 antibody using aquaporin-4 extracellular loop-based carbon nanotube biosensor for the diagnosis of neuromyelitis optica.
Cytokine-Defined B Cell Responses as Therapeutic Targets in Multiple Sclerosis.
Pages
« first
‹ previous
…
554
555
556
557
558
559
560
561
562
…
next ›
last »